Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first FDA approval after 27 years of development. https://t.co/tPZKCxLF8j ...

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug development. https://t.co/he7YfIMlD0 ...

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug development. https://t.co/lzAcv7ORKv ...

- There's definitely a point where you're just like, I'm going to have to live like this forever. - I've been on antidepressants since I was 13 year and never really got away from depression. - Spravato has become a big success for Johnson and - Johnson.The patient will feel sleepy. They will feel as though they're floating. They can feel detached from themselves.That's the physical part of this treatment. The patient's psychological response differs, and there's very few things I can do to prepare patients ...

Even if you aren't familiar with the name Abby, you've probably seen some of their commercials. >> There's nothing like clearer skin and better movement. >> This week, the company delivered a solid earnings beat driven by its immunology portfolio of drugs that sent the stock up, recovering from recent losses.Yet, investors, they remain on edge. Aby is the undisputed titan of the hundred billion dollar autoimmune disease market. It treats conditions like psoriasis, arthritis, Crohn's disease.For over two dec ...

Leo Pharma has picked more banks to help it prepare for a possible initial public offering in Copenhagen, according to people familiar with the matter. https://t.co/BN5vBXwyuK ...

Drugmakers are crowding into a market that has barely evolved in decades with new treatments for millions of Americans who are losing their hair. https://t.co/sTKrNFWEaG ...

AstraZeneca failed to persuade a US regulatory review panel about the benefits of its novel breast cancer medicine, throwing a hurdle in front of a key drug in the company’s pipeline. https://t.co/6oiaGq7Hcv ...

and thank you for inviting me TEDex 2025. The topic is atoms to outcomes. So as you may already know, I am a chemist.I'm a scientist in chemistry and atoms are the building blocks of any molecules or anything whatever you seen is are the fundamental particles atoms atoms combined to form molecules and molecules organized to form systems very highly complicated system whatever you see here these are the manifestations of several atoms So as you can see the complexity is not built on one day. It's a stepbyste ...

Bristol Myers Squibb posted higher first-quarter revenue boosted by its portfolio of newer treatments for heart and blood conditions. https://t.co/Bz8u2pGmz1 ...